vs

Side-by-side financial comparison of SS Innovations International, Inc. (SSII) and SurgePays, Inc. (SURG). Click either name above to swap in a different company.

SurgePays, Inc. is the larger business by last-quarter revenue ($16.2M vs $14.5M, roughly 1.1× SS Innovations International, Inc.). SS Innovations International, Inc. runs the higher net margin — -17.0% vs -85.6%, a 68.6% gap on every dollar of revenue. On growth, SS Innovations International, Inc. posted the faster year-over-year revenue change (79.1% vs 68.7%). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs -28.2%).

SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.

SurgePays, Inc. is a U.S.-headquartered fintech and telecommunications company focused on serving underbanked and low-income communities across the country. It offers prepaid wireless plans, reloadable debit cards, digital banking solutions, and daily consumer products through a nationwide network of independent local retail partners such as convenience stores.

SSII vs SURG — Head-to-Head

Bigger by revenue
SURG
SURG
1.1× larger
SURG
$16.2M
$14.5M
SSII
Growing faster (revenue YoY)
SSII
SSII
+10.4% gap
SSII
79.1%
68.7%
SURG
Higher net margin
SSII
SSII
68.6% more per $
SSII
-17.0%
-85.6%
SURG
Faster 2-yr revenue CAGR
SSII
SSII
Annualised
SSII
99.9%
-28.2%
SURG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SSII
SSII
SURG
SURG
Revenue
$14.5M
$16.2M
Net Profit
$-2.5M
$-13.9M
Gross Margin
43.9%
-14.8%
Operating Margin
-3.7%
-79.1%
Net Margin
-17.0%
-85.6%
Revenue YoY
79.1%
68.7%
Net Profit YoY
-28.5%
30.0%
EPS (diluted)
$-0.01
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SSII
SSII
SURG
SURG
Q4 25
$14.5M
$16.2M
Q3 25
$12.8M
$18.7M
Q2 25
$10.0M
$11.5M
Q1 25
$5.1M
$10.6M
Q4 24
$8.1M
$9.6M
Q3 24
$4.4M
$4.8M
Q2 24
$4.5M
$15.1M
Q1 24
$3.6M
$31.4M
Net Profit
SSII
SSII
SURG
SURG
Q4 25
$-2.5M
$-13.9M
Q3 25
$-3.7M
$-7.5M
Q2 25
$-256.7K
$-7.1M
Q1 25
$-5.7M
$-7.6M
Q4 24
$-1.9M
$-19.8M
Q3 24
$-3.2M
$-14.3M
Q2 24
$-4.1M
$-12.9M
Q1 24
$-9.8M
$1.2M
Gross Margin
SSII
SSII
SURG
SURG
Q4 25
43.9%
-14.8%
Q3 25
48.1%
-13.9%
Q2 25
59.1%
-23.0%
Q1 25
21.2%
-27.8%
Q4 24
48.9%
-117.0%
Q3 24
52.8%
-164.2%
Q2 24
31.9%
-22.8%
Q1 24
20.0%
26.0%
Operating Margin
SSII
SSII
SURG
SURG
Q4 25
-3.7%
-79.1%
Q3 25
-14.3%
-37.2%
Q2 25
1.0%
-59.1%
Q1 25
-115.6%
-71.7%
Q4 24
-22.7%
-209.0%
Q3 24
-73.1%
-299.4%
Q2 24
-90.9%
-72.1%
Q1 24
-270.3%
5.6%
Net Margin
SSII
SSII
SURG
SURG
Q4 25
-17.0%
-85.6%
Q3 25
-29.0%
-40.1%
Q2 25
-2.6%
-61.5%
Q1 25
-111.0%
-72.2%
Q4 24
-23.7%
-206.5%
Q3 24
-74.0%
-299.3%
Q2 24
-91.8%
-85.3%
Q1 24
-270.5%
3.9%
EPS (diluted)
SSII
SSII
SURG
SURG
Q4 25
$-0.01
$-0.68
Q3 25
$-0.02
$-0.38
Q2 25
$0.00
$-0.36
Q1 25
$-0.03
$-0.38
Q4 24
$-0.01
$-1.07
Q3 24
$-0.02
$-0.73
Q2 24
$-0.02
$-0.66
Q1 24
$-0.06
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SSII
SSII
SURG
SURG
Cash + ST InvestmentsLiquidity on hand
$3.2M
$1.7M
Total DebtLower is stronger
$13.3M
Stockholders' EquityBook value
$38.2M
$-15.3M
Total Assets
$74.2M
$8.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SSII
SSII
SURG
SURG
Q4 25
$3.2M
$1.7M
Q3 25
$5.7M
$2.5M
Q2 25
$11.4M
$4.4M
Q1 25
$15.9M
$5.4M
Q4 24
$466.5K
$11.8M
Q3 24
$220.4K
$23.7M
Q2 24
$608.2K
Q1 24
$948.1K
Total Debt
SSII
SSII
SURG
SURG
Q4 25
$13.3M
Q3 25
$12.0M
Q2 25
$9.6M
Q1 25
$3.6M
Q4 24
$4.0M
Q3 24
$4.4M
Q2 24
$4.8M
Q1 24
$5.2M
Stockholders' Equity
SSII
SSII
SURG
SURG
Q4 25
$38.2M
$-15.3M
Q3 25
$39.6M
$-6.4M
Q2 25
$42.0M
$116.1K
Q1 25
$40.6M
$7.8M
Q4 24
$13.5M
$15.3M
Q3 24
$13.7M
$33.2M
Q2 24
$14.8M
$46.2M
Q1 24
$16.7M
$56.0M
Total Assets
SSII
SSII
SURG
SURG
Q4 25
$74.2M
$8.5M
Q3 25
$69.6M
$14.5M
Q2 25
$70.0M
$15.2M
Q1 25
$63.5M
$15.7M
Q4 24
$42.4M
$24.0M
Q3 24
$39.0M
$41.5M
Q2 24
$35.7M
$56.4M
Q1 24
$35.2M
$69.6M
Debt / Equity
SSII
SSII
SURG
SURG
Q4 25
Q3 25
Q2 25
82.67×
Q1 25
0.46×
Q4 24
0.26×
Q3 24
0.13×
Q2 24
0.10×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SSII
SSII
SURG
SURG
Operating Cash FlowLast quarter
$-1.5M
$-3.6M
Free Cash FlowOCF − Capex
$-3.2M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
11.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SSII
SSII
SURG
SURG
Q4 25
$-1.5M
$-3.6M
Q3 25
$-7.5M
$-4.6M
Q2 25
$-3.5M
$-6.1M
Q1 25
$-6.1M
$-7.0M
Q4 24
$-3.3M
$-7.9M
Q3 24
$-2.5M
$-13.3M
Q2 24
$-1.0M
$-4.1M
Q1 24
$-2.7M
$4.0M
Free Cash Flow
SSII
SSII
SURG
SURG
Q4 25
$-3.2M
Q3 25
$-8.2M
Q2 25
$-3.8M
Q1 25
$-7.0M
Q4 24
$-3.4M
Q3 24
$-4.2M
Q2 24
$-3.1M
Q1 24
$-2.8M
FCF Margin
SSII
SSII
SURG
SURG
Q4 25
-22.3%
Q3 25
-64.1%
Q2 25
-37.7%
Q1 25
-136.2%
Q4 24
-41.7%
Q3 24
-96.9%
Q2 24
-69.5%
Q1 24
-76.9%
Capex Intensity
SSII
SSII
SURG
SURG
Q4 25
11.8%
Q3 25
5.9%
Q2 25
3.2%
Q1 25
17.0%
Q4 24
1.5%
Q3 24
38.8%
Q2 24
46.8%
Q1 24
3.5%
Cash Conversion
SSII
SSII
SURG
SURG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
3.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SSII
SSII

System Sales$13.4M92%
Other$1.2M8%

SURG
SURG

Segment breakdown not available.

Related Comparisons